Back

Cardiac transplantation in transthyretin amyloid cardiomyopathy: outcomes from three decades of tertiary centre experience

29 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Yousuf Razvi

University College London, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis
Doctor A. Ioannou (Greater London, GB)
Abstract Slides
Presentation thumbnail
Transthyretin amyloid cardiomyopathy: a 2-year single-centre experience
Doctor B. Rocha (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?
Doctor R. Rettl (Vienna, AT)
Abstract Slides
Presentation thumbnail
Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms
Doctor G. Neculae (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Detection of arrhythmias in patients with cardiac amyloidosis using implantable ECG recorders.
Professor M. Taborsky (Usti Nad Labem, CZ)
Abstract Slides

Access the full session

Session thumbnail
Cardiac amyloidosis

The Event

Event poster

ESC Congress 2022

29 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources